Annotation Detail for NCAN
Basic Information
Top
Pathway ID | Pathway Name |
---|
| Axon guidance |
Pathway ID | Pathway Name |
---|
200170 | Syndecan-3-mediated signaling events |
Pathway ID | Pathway Name |
---|
500097 | L1CAM interactions |
500087 | NCAM1 interactions |
Desease Name |
---|
METABOLIC |
LDL cholesterol |
triglycerides |
cholesterol, total |
Desease Name |
---|
Cholesterol, total |
Triglycerides |
LDL cholesterol |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of NCAN mRNA | increases expression | 16788091
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NCAN mRNA | affects expression | 16483693
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of NCAN mRNA | increases expression | 16644059
|
D003024 |
Clozapine |
Clozapine results in decreased expression of NCAN mRNA | decreases expression | 18797397
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of NCAN mRNA | decreases expression | 18797397
|
C076029 |
olanzapine |
olanzapine results in decreased expression of NCAN mRNA | decreases expression | 18797397
|
C035988 |
procymidone |
procymidone results in increased expression of NCAN mRNA | increases expression | 15686871
|
C025643 |
vinclozolin |
vinclozolin results in increased expression of NCAN mRNA | increases expression | 15686871
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.36 | 12649775 14617031 16160616 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.83 | 19015723 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.84 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.84 | 17069543 18685284 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
4.08 | 15700767 16011737 15673190 10355542 16050911 16097048 16192424 18705752 3786805 16124888 15721981 16227642 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
1.85 | 18788625 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.25 | 15215559 1977408 |
MESH:D002389 |
Catatonia |
|
olanzapine |
6.63 | 18071103 16772815 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.27 | 17123785 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.62 | 14966744 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
5.10 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.82 | 11575062 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.84 | 17069543 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
3.02 | 16402076 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.93 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
2.09 | 7440962 7179309 2869522 3786805 9327722 21278145 16227642 15998439 4309450 6623471 17522070 6884620 19085960 3732212 15968718 7120509 16177239 10092053 11566570 10915739 15027814 19336974 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.35 | 16402076 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
3.41 | 12631006 17595544 15959796 61145 16239168 19224547 12795759 16045604 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.76 | 18705752 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.27 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.68 | 16417039 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.88 | 19900420 19110552 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.87 | 16899240 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.25 | 16046005 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
6.57 | 17933447 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.39 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.19 | 16467254 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.07 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.13 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.92 | 21278145 17174718 16943688 17157831 17334410 11903743 11408273 16221502 16239168 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
1.75 | 16136751 17708605 14512876 15052691 15370692 15893842 12666154 16033810 17823541 17631135 16011737 16248980 18251166 15650968 18277467 16192424 16015684 17805973 12445418 18187930 17714472 10355542 17976157 17565644 12649538 12741479 14716833 15057751 15931870 18156304 18472094 18429990 15818738 20821823 17922224 17900296 18395095 17525996 18412020 18317297 17557913 12586293 12609069 17640975 12389079 12632512 18054572 18166357 17698563 17944888 17481882 12632514 17869086 15673190 18395914 14724832 15925388 15730626 18420326 18418968 12898905 15123356 18006644 16027843 16638106 16116963 14620537 15338365 18263696 16097048 14716496 18279442 12546737 13678700 18472332 17761835 14748882 12445421 18376398 15996030 15876570 12667390 15362042 18481824 12958196 18705752 17766677 17721639 18205269 18339082 15959796 11481614 18210741 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.13 | 17285989 15720792 16246199 15830285 16964402 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.47 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.92 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
2.29 | 19294768 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
2.75 | 12014681 15583823 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.91 | 20210726 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
15.52 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
15.52 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
15.52 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.63 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.61 | 19142101 |
MESH:D009765 |
Obesity |
|
Clozapine |
5.57 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
olanzapine |
5.57 | 18515891 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.23 | 19015723 18220299 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.27 | 18220299 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.27 | 18629315 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
12.86 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
12.86 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.72 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.72 | 11575062 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
6.08 | 11151749 18855531 18806925 11763009 19369910 20580759 17123785 20168265 16141801 20452607 20521320 17726453 17667964 20107430 20521326 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
6.08 | 20107430 18513383 19369910 1830565 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
6.08 | 20107430 20521326 17726453 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
11.91 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
11.91 | 20210726 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
11.07 | 16141801 17502770 16402076 20107430 20564506 20521320 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
11.07 | 20107430 17933447 19434072 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.41 | 17933447 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB02379 |
- |
Beta-D-Glucose |
Sweetening Agents |
DB04396 |
- |
Thiodigalactoside |
|